MedTrace Logo

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

NCT03307044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-03-20

No results posted yet for this study

Summary

This pilot clinical trial studies how well fraction carbon dioxide (CO2) laser therapy works in treating vaginal atrophy in patients with breast cancer. Fraction CO2 laser therapy uses intense beams of light to cut, burn, or destroy tissue and may remodel vaginal tissue and direct controlled thermal damage of vaginal mucosa.

Conditions

  • Breast Carcinoma
  • Cancer Survivor
  • Cervical Carcinoma
  • Dyspareunia
  • Vaginal Dryness

Interventions

PROCEDURE

Laser Therapy

Undergo fractional CO2 laser therapy

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Allison Quick, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-16
Primary Completion
2018-12-21
Completion
2022-05-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03307044 on ClinicalTrials.gov